Insider · CIK 0001893729
Darius Kharabi
Files at KALA (KALA BIO, Inc.). First filing Jan 7, 2025, latest Oct 24, 2025.
Darius Kharabi files SEC Form 4 as officer at KALA (KALA BIO, Inc.). Since Jan 7, 2025, Darius Kharabi has reported 0 open-market buys worth $0 and 4 open-market sells worth $54k, the latest filed on Oct 24, 2025.
A track record needs three past buys with six months of prices behind them; Darius Kharabi has 0, so none is measured yet.
The newest scored trade: sold $17k of KALA on Oct 22, 2025, filed Oct 24, 2025, scored 40 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $17k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KALA: KALA BIO, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | KALA BIO, Inc. | $17k 20,806 shares | -33% | 0% from low-96% from high | |
| 10Weak | KALA BIO, Inc. | $18k 4,511 shares | -7% | +36% from low-64% from high | |
| 10Weak | KALA BIO, Inc. | $2,730 730 shares | -1% | +39% from low-63% from high | |
| 10Weak | KALA BIO, Inc. | $15k 2,021 shares | -3% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 22, 2025 | KALA KALA BIO, Inc. | 20,806 0.30% of outstanding | $17k | Oct 22, 2025 | none |
| Jun 24, 2025 | KALA KALA BIO, INC. | 4,511 0.07% of outstanding | $18k | Jun 24, 2025 | $2,730 |
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 22, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock | -20,806 | $0.83 | $17k | 41,760 | Oct 24, 2025 |
| Jun 24, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -4,511 | $4.01 | $18k | 62,566 | Jun 26, 2025 |
| Jun 3, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -730 | $3.74 | $2,730 | 67,077 | Jun 4, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | AGrant or award Common Stock | +10,100 | $0.00 | $0 | 69,828 | Jan 7, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | SOpen-market sale Common Stock10b5-1 | -2,021 | $7.63 | $15k | 67,807 | Jan 7, 2025 |
| Jan 6, 2025 | KALA KALA BIO, Inc. | AGrant or award Stock Option (right to buy)derivative | +45,200 | $0.00 | $0 | 45,200 | Jan 7, 2025 |
Questions about Darius Kharabi
Answered from the filings on this page, as of the latest one.
Is Darius Kharabi buying or selling?
In the last 12 months Darius Kharabi reported 0 open-market buys worth $0 and 1 open-market sell worth $17k on SEC Form 4; the latest was sold $17k of KALA on Oct 22, 2025. Grants, option exercises and tax withholding are not counted.
How did Darius Kharabi's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Darius Kharabi has 0.
Where does Darius Kharabi file Form 4?
Darius Kharabi has filed Form 4 at KALA (KALA BIO, Inc.) as CHIEF BUSINESS OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.